Mylan to Present at the 35th Annual J.P. Morgan Healthcare Conference

HERTFORDSHIRE, England and PITTSBURGH, Jan. 9, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that CEO Heather Bresch will present at the 35th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 11, 2017, in San Francisco. The presentation is scheduled to begin at 9:00 a.m. PST (12:00 p.m. EST).

Interested parties can access a live webcast of the presentation via the investor relations section of Mylan's Web site at www.mylan.com/investors. An archived version will also be available following the live presentation and can be accessed at the same location for a limited time.

Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 2,700 generic and branded pharmaceuticals, including antiretroviral therapies on which approximately 50% of people being treated for HIV/AIDS worldwide depend. We market our products in more than 165 countries and territories. Our global R&D and manufacturing platform includes more than 50 facilities, and we are one of the world's largest producers of active pharmaceutical ingredients. Every member of our more than 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at mylan.com.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mylan-to-present-at-the-35th-annual-jp-morgan-healthcare-conference-300387657.html

SOURCE Mylan N.V.

Copyright 2017 PR Newswire